BEIJING QUANTOBIO BIOTECHNOLOGY

QuantoBio was established in September 2009 by a group of "returnees" entrepreneurial team, Morningside Ventures, Vcanland, a large domestic biotechnology industry group, and TusPark Ventures. QuantoBio has set up 4 technology platform: Molecular Biology, Molecular immunology , Cell immunology, Protein engineering, QuantoBio is a leading supplier for research reagents with top tier technology in Molecular Bio-chemistry Immunology, especially in MicroRNA ,Flow Cytometry Elispot and Tetramer , Aimplex, and provide series clinical products including Flow antibody, molecular diagnostics, protein immunology that focusing in Cancer /Infection Disease and related Healthcare management... QuantoBio undertakes and takes part in multiple government research and development topics such as "11th Five Year" and"12th Five Year" National Science and Technology Major Projects, health industry special research and so on, with 13 national invention patents, 1 computer software copyrights, 3 registered..

Also known as: Beijing Quantobio Biotechnology Co., Ltd

Primary location: Beijing China